Overview
Louise Helander is a Transfusion Medicine provider in Aurora, Colorado. Her top areas of expertise are Immunodeficiency with Hyper IgM Type 1 and Chronic Granulomatous Disease.
Her clinical research consists of co-authoring 8 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- PPO
Locations
13123 E 16th Ave, Aurora, CO 80045
1665 Aurora Ct Fl 2, Aurora, CO 80045
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Healthone Irl Pathology Services LLC
Amy Schmidt is a Hematologist Oncology specialist and a Transfusion Medicine provider in Denver, Colorado. Dr. Schmidt is highly rated in 1 condition, according to our data. Her top areas of expertise are Hemolytic Transfusion Reaction, Thrombocytopenia, Acute Myeloid Leukemia (AML), and Iron Deficiency Anemia.
University Of Colorado Hospital
Nicole Draper is a Transfusion Medicine provider in Aurora, Colorado. Her top areas of expertise are Smoldering Multiple Myeloma, Childhood Acute Myeloid Leukemia, and Relapsed Refractory Multiple Myeloma (RRMM).
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Chronic Granulomatous DiseaseDr. Helander isExperienced. Learn about Chronic Granulomatous Disease.
- Immunodeficiency with Hyper IgM Type 1Dr. Helander isExperienced. Learn about Immunodeficiency with Hyper IgM Type 1.